Detection of SMARCB1 gene mutations in Egyptian hepatocellular carcinoma patients using targeted next-generation sequencing: A pilot study
Last updated: 04 Jan 2025
10.21608/rjab.2021.299278
Hepatocellular carcinoma (HCC), next generation sequencing (NGS), SMARCB1 gene, genetic alternations
Sara
Marzok
M
Department of Molecular Diagnostics and Therapeutics, Genetic Engineering & Biotechnology Research Institute, University of Sadat City, Egypt
sara_marzok@hotmail.com
Manal
Elhamshary
O
Department of Molecular Diagnostics and Therapeutics, Genetic Engineering & Biotechnology Research Institute, University of Sadat City, Egypt
manal.elhamshary@gebri.usc.edu.eg
Osama
Shalan
F
Department of Molecular Diagnostics and Therapeutics, Genetic Engineering & Biotechnology Research Institute, University of Sadat City, Egypt.
Randa
Talaat
M.
Molecular Diagnostics and Therapeutics Department, Genetic Engineering & Biotechnology Research Institute (GEBRI), University of Sadat City (USC), Elsadat city, Egypt.
randa.mohamed@gebri.usc.edu.eg
Mahmoud
Nasr
I
Department of Molecular Biology, Genetic Engineering & Biotechnology Research Institute, University of Sadat City, Egypt
Moustafa
Sakr
Department of Molecular Diagnostics and Therapeutics, Genetic Engineering & Biotechnology Research Institute, University of Sadat City, Egypt.
mostafa.sakr@gebri.usc.edu.eg
Sadat City
0000-0002-5873-8468
Mohamed
Khalifa
K
Children Cancer Hospital, 57357, Egypt.
Ehab
Ahmed
A
Chemistry department, Faculty of science, Cairo University, Egypt.
Ghada
Nasr
M
Department of Molecular Diagnostics and Therapeutics, Genetic Engineering & Biotechnology Research Institute, University of Sadat City, Egypt.
ghada.nasr@gebri.usc.edu.eg
7
1
31936
2021-06-01
2021-04-15
2021-06-30
1
14
2356-9433
2682-3470
https://rjab.journals.ekb.eg/article_299278.html
https://rjab.journals.ekb.eg/service?article_code=299278
1
Original Article
890
Journal
Research Journal of Applied Biotechnology
https://rjab.journals.ekb.eg/
Detection of SMARCB1 gene mutations in Egyptian hepatocellular carcinoma patients using targeted next-generation sequencing: A pilot study
Details
Type
Article
Created At
24 Dec 2024